Opinion: Canada should block a patent waiver for COVID vaccines
Opinion: Canada should block a patent waiver for COVID vaccines Special to Financial Post © Provided by Financial Post A nurse prepares to administer the AstraZeneca/Oxford vaccine under the COVAX scheme against the coronavirus disease (COVID-19) at the Eka Kotebe General Hospital in Addis Ababa, Ethiopia. Global Affairs Canada still has not come to a decision on whether to support an intellectual property rights waiver for COVID-19 vaccines. Canada, along with the U.S., EU, U.K., Switzerland, Japan, Norway, Australia and Brazil, have all delayed deciding on the “TRIPS w...